Skip to main content
Saheli Sadanand on Muck Rack

Saheli Sadanand

Verified
New York
As seen in: Nature Medicine, Nature, The Journal of Immunology
Deputy Editor @NatureMedicine | Handling research in #oncology #immunology #immunotherapy | Follow me on Bluesky! @sahelisadanand.bsky.social
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Saheli

Contact Saheli, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immunotherapy for esophageal cancer

|
By Saheli Sadanand Verified
| Nature Verified
Postdoctoral Fellow/Physiology The University of Tennessee Health Science Center (UTHSC) Memphis, TN, United States JOB POST
Open in Who Shared View Duplicates (2) Issue with article?

CAR T cells drive multiple myeloma out

|
By Saheli Sadanand Verified
| Nature Verified
Engineered T cells that recognize a protein expressed on myeloma cells show promise in a clinical trial. Engineered T cells that recognize a protein expressed on myeloma cells show promise in a clinical trial.
Open in Who Shared Issue with article?

A synovial biopsy-driven trial in rheumatoid arthritis

|
By Saheli Sadanand Verified
| Nature Verified
Image credit: Peter Dazeley / The Image Bank Some patients with rheumatoid arthritis respond to treatment with rituximab, a B cell–depleting antibody given after other therapies fail, whereas others show poor responses. At present there are no reliable blood biomarkers that can help in the prediction of rituximab’s efficacy.
Open in Who Shared Issue with article?
See all 6 articles